retatrutide ly3437943 triple agonist glp-1 gip glucagon Eli Lilly just announced striking Phase 3 results for retatrutide, an experimental “triple agonist” that acts on three gut-hormone targets at once. On the top dose, people lost an average of 28% retatrutide

A vendor selling 98% purity retatrutide who provides an HPLC chromatogram, mass spectrometry data, and batch-specific testing results is operating at a fundamentally different level than one who simply prints "98% purity" on a label

Competing interests Nik Krajnc: has participated in meetings sponsored by, received speaker honoraria or travel funding from BMS/Celgene, Janssen-Cilag, Merck, Novartis, Roche and Sanofi-Genzyme and held a grant for a Multiple Sclerosis Clinical Training Fellowship Programme from the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS)

A POTS patient who needed to take 2-3 times more time to get her college work done, reported she no longer had brain fog and was able to do her work in a third of the time

Weight Loss Rates and Timelines One of the most common questions among couples or friends considering Retatrutide together is who will see results first

p = 0.02) in this population